Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
4.750
+0.230 (5.09%)
At close: Feb 6, 2026, 4:00 PM EST
4.730
-0.020 (-0.42%)
After-hours: Feb 6, 2026, 5:45 PM EST
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $224.36 million as of February 6, 2026. Its market cap has decreased by -12.16% in one year.
Market Cap
224.36M
Enterprise Value
122.35M
1-Year Change
-12.16%
Ranking
Category
Stock Price
$4.75
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $224.36M, a decrease of -58.33%. That is a compound annual growth rate of -14.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 224.36M | -21.88% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shattuck Labs | 225.28M |
| Cabaletta Bio | 224.30M |
| Palisade Bio | 223.50M |
| Climb Bio | 222.01M |
| Heron Therapeutics | 221.87M |
| MediWound | 220.72M |
| Nuvectis Pharma | 216.45M |
| Inhibikase Therapeutics | 216.12M |